Pharmafile Logo
Pharmafocus logo
Advanced Search

Fresh scrutiny for new diabetes drugs

September 15, 2011
Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes

Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …

News

Daiichi Sankyo subsidiary gets FDA warning

September 15, 2011
Daiichi Sankyo, FDA, Luitpold

Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …

News
Blog footer

Digital Pharma: Lilly plans social media expansion

September 14, 2011
Medical Communications Digital Pharma blog, Facebook, lilly, social media, youtube

One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …

News

First Paediatric Use Marketing Authorisation Granted

September 14, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …

News
Press release

GSK-Merck back new developing world cancer charity

September 14, 2011
Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer

GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …

News
Merck & Co

Merck collaborates with China-based genomics specialist BGI

September 14, 2011
Research and Development BGI, Merck & Co, biomarkers, genomics

Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …

News
US Food and Drug Administration

FDA unveils changes to cancer drug review

September 14, 2011
Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs

The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …

News
GlaxoSmithKline

GSK-Amicus start late-stage trials of Fabry disease treatment

September 14, 2011
Research and Development Amicus Therapeutics, Fabry disease, GSK

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …

News

Novartis loses global development head to Gates Foundation

September 14, 2011
Research and Development Bill and Melinda Gates Foundation, Novartis, appointment

Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …

News

Government bites the bullet over A&E closure

September 14, 2011
NHS, NHS reform, hosptials

The government has backed the closure of the Accident and Emergency department at Chase Farm hospital in London, ending years …

News

The recast of the Restriction of Hazardous Substances (RoHS) Directive

September 13, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …

News
Press release
Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011
Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …

News
Shanghai China flag

Betting big on research in China

September 13, 2011
Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …

Feature

AM-Pharma appoints new chief executive

September 13, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …

Appointment
Genzyme

Genzyme confirms further Fabrazyme delay

September 13, 2011
Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news

Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …

News

Slow Provenge growth prompts Dendreon staff cull

September 13, 2011
Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news

After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …

News

Aurobindo forms Russian joint venture with Diod

September 13, 2011
Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news

Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …

News

Offshoring pharma manufacturing increases risk, says study

September 12, 2011
Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news

Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …

News

Pharma manufacturing news in brief

September 12, 2011
Manufacturing and Production pharma manufacturing news

DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …

News
research_partnership_richard_head

Richard Head joins the Research Partnership

September 12, 2011
Sales and Marketing appointment, sales and marketing

Market research company the Research Partnership has appointed Richard Head as a director. He will be based at the company’s …

Appointment
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026